Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Chun-Yang Fan

Concepts (278)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
14
2010
288
1.680
Why?
Carcinoma, Squamous Cell
15
2010
326
1.600
Why?
DNA Methylation
13
2009
548
1.090
Why?
DNA Glycosylases
5
2011
19
1.020
Why?
Promoter Regions, Genetic
11
2009
455
1.010
Why?
Gene Silencing
7
2009
114
1.010
Why?
Mitochondria
3
2011
400
0.510
Why?
DNA Repair
5
2008
187
0.500
Why?
Adaptor Proteins, Signal Transducing
5
2009
200
0.460
Why?
Polymerase Chain Reaction
11
2009
447
0.460
Why?
Kidney Neoplasms
2
2008
174
0.460
Why?
Carcinoma, Non-Small-Cell Lung
2
2007
153
0.450
Why?
Nuclear Proteins
5
2009
235
0.450
Why?
DNA, Neoplasm
10
2008
144
0.440
Why?
Neoplasm Proteins
4
2005
320
0.400
Why?
Laryngeal Neoplasms
3
2007
43
0.380
Why?
Vascular Endothelial Growth Factor A
2
2009
180
0.360
Why?
CpG Islands
3
2008
107
0.360
Why?
Lung Neoplasms
2
2007
597
0.340
Why?
Microsatellite Instability
1
2009
19
0.330
Why?
Fatty Liver
1
2011
130
0.330
Why?
Immunohistochemistry
7
2012
955
0.320
Why?
Mitochondrial Proteins
2
2007
87
0.320
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
22
0.310
Why?
Port-Wine Stain
1
2008
14
0.300
Why?
Oxygen
1
2011
319
0.300
Why?
O(6)-Methylguanine-DNA Methyltransferase
2
2005
9
0.290
Why?
Genes, p16
3
2005
8
0.280
Why?
Lymph Nodes
2
2007
256
0.280
Why?
Skin
3
2010
382
0.280
Why?
DNA, Mitochondrial
4
2011
110
0.280
Why?
N-Glycosyl Hydrolases
1
2007
6
0.280
Why?
Carcinoma, Renal Cell
1
2008
101
0.280
Why?
DNA-(Apurinic or Apyrimidinic Site) Lyase
1
2007
15
0.270
Why?
Aged
15
2011
9738
0.270
Why?
Adenoma
1
2008
113
0.270
Why?
Mitochondria, Liver
1
2007
69
0.270
Why?
Cisplatin
3
2007
283
0.260
Why?
Proteoglycans
2
2003
81
0.250
Why?
Fibroma
1
2006
39
0.250
Why?
Aged, 80 and over
8
2009
3233
0.240
Why?
Liver
1
2011
1126
0.240
Why?
Membrane Glycoproteins
2
2003
246
0.230
Why?
Survival Analysis
5
2009
658
0.230
Why?
Middle Aged
16
2011
12579
0.230
Why?
Carcinoma, Hepatocellular
1
2007
191
0.230
Why?
Humans
36
2013
50419
0.230
Why?
Prognosis
7
2007
1974
0.220
Why?
DNA Repair Enzymes
1
2004
42
0.220
Why?
Ataxia Telangiectasia
1
2004
6
0.220
Why?
Salivary Ducts
1
2003
3
0.220
Why?
Salivary Gland Neoplasms
1
2003
7
0.220
Why?
Adenocarcinoma, Clear Cell
1
2003
34
0.210
Why?
Receptors, Cytoplasmic and Nuclear
1
2003
66
0.210
Why?
Liver Neoplasms
1
2007
321
0.210
Why?
Obesity
1
2011
1123
0.200
Why?
Adult
14
2011
13561
0.200
Why?
Female
22
2012
27053
0.190
Why?
Nitric Oxide Synthase Type III
2
2013
77
0.190
Why?
Male
21
2012
25866
0.190
Why?
Epigenesis, Genetic
1
2004
371
0.170
Why?
Transcription Factors
1
2003
561
0.170
Why?
Antineoplastic Agents
2
2010
1165
0.170
Why?
Skin Transplantation
2
2010
43
0.160
Why?
Carrier Proteins
4
2005
297
0.160
Why?
Skin Neoplasms
4
2008
492
0.150
Why?
Tumor Suppressor Proteins
2
2011
127
0.150
Why?
Loss of Heterozygosity
2
2008
75
0.140
Why?
DNA Damage
2
2011
299
0.140
Why?
Survival Rate
3
2009
906
0.140
Why?
Neoplasm Invasiveness
4
2007
269
0.130
Why?
Graft Survival
3
2011
160
0.120
Why?
Ki-67 Antigen
2
2011
55
0.120
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
568
0.120
Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
2005
34
0.110
Why?
Algorithms
2
2008
624
0.110
Why?
Cadherins
2
2005
61
0.110
Why?
Immunoenzyme Techniques
4
2013
140
0.110
Why?
Prostatic Neoplasms
2
2008
386
0.110
Why?
Thyroid Neoplasms
2
2007
109
0.110
Why?
Keratosis
2
2003
14
0.110
Why?
Base Sequence
2
2004
622
0.100
Why?
Receptors, Cell Surface
1
2013
117
0.100
Why?
Wound Healing
2
2010
183
0.100
Why?
Carcinoma in Situ
2
2003
73
0.100
Why?
Lymphangioma, Cystic
1
2011
10
0.100
Why?
Laryngectomy
3
2007
27
0.100
Why?
Leukoplakia, Oral
1
2011
6
0.090
Why?
Aminolevulinic Acid
1
2011
8
0.090
Why?
Endothelium, Lymphatic
1
2011
12
0.090
Why?
Lasers, Dye
1
2011
10
0.090
Why?
Arteriovenous Malformations
1
2013
76
0.090
Why?
Cell Line, Tumor
4
2010
1393
0.090
Why?
Antigens, CD
1
2013
221
0.090
Why?
Photosensitizing Agents
1
2011
19
0.090
Why?
Propranolol
1
2012
79
0.090
Why?
Lymphatic Abnormalities
1
2011
22
0.090
Why?
Microtubule-Associated Proteins
1
2011
66
0.090
Why?
Photochemotherapy
1
2011
33
0.090
Why?
Biopsy
3
2011
588
0.090
Why?
Homeodomain Proteins
1
2011
79
0.090
Why?
Laser Therapy
1
2011
83
0.090
Why?
Taxoids
1
2010
37
0.090
Why?
Drug Resistance, Multiple
1
2010
24
0.090
Why?
Hemangioma
1
2012
83
0.090
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2010
57
0.080
Why?
Gene Deletion
1
2011
260
0.080
Why?
Follow-Up Studies
4
2011
2231
0.080
Why?
Neoplasm Staging
3
2007
738
0.080
Why?
Gene Expression Regulation, Neoplastic
4
2010
831
0.080
Why?
Mice, Transgenic
1
2011
537
0.080
Why?
Disease Models, Animal
2
2011
1431
0.080
Why?
Animals
8
2011
13063
0.080
Why?
Paraffin Embedding
1
2008
51
0.080
Why?
Drug Resistance, Neoplasm
1
2010
315
0.080
Why?
Mice
4
2011
5659
0.080
Why?
Sulfites
1
2008
1
0.080
Why?
Microsatellite Repeats
1
2008
37
0.070
Why?
Blood Glucose
1
2011
447
0.070
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
997
0.070
Why?
Neoplasm Seeding
1
2008
4
0.070
Why?
Chordoma
1
2008
8
0.070
Why?
Skull Base Neoplasms
1
2008
20
0.070
Why?
Recurrent Laryngeal Nerve
1
2007
12
0.070
Why?
Laryngeal Nerves
1
2007
15
0.070
Why?
Apoptosis Regulatory Proteins
2
2005
82
0.070
Why?
Receptors, Thyrotropin
1
2007
8
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2005
59
0.070
Why?
Methylation
2
2007
117
0.070
Why?
Symporters
1
2007
17
0.070
Why?
Cell Proliferation
1
2011
980
0.070
Why?
Pattern Recognition, Automated
1
2007
40
0.070
Why?
Image Enhancement
1
2007
54
0.070
Why?
Risk Factors
3
2008
3712
0.070
Why?
Precancerous Conditions
1
2008
83
0.070
Why?
Prostate
1
2008
114
0.070
Why?
Carcinoma, Papillary
1
2007
47
0.070
Why?
Transgenes
1
2007
50
0.070
Why?
Neoplasm Recurrence, Local
2
2008
622
0.070
Why?
MicroRNAs
1
2010
345
0.070
Why?
Image Interpretation, Computer-Assisted
1
2007
105
0.070
Why?
Child
5
2012
6931
0.070
Why?
Child, Preschool
3
2012
3953
0.070
Why?
Cell Nucleus
1
2007
183
0.070
Why?
Genomics
1
2008
238
0.070
Why?
Syndecans
2
2003
35
0.070
Why?
RNA, Messenger
2
2007
1085
0.070
Why?
Protein Transport
1
2007
183
0.070
Why?
Syndecan-1
2
2003
73
0.060
Why?
Artificial Intelligence
1
2007
97
0.060
Why?
Adenomatous Polyposis Coli Protein
1
2005
2
0.060
Why?
Receptors, Atrial Natriuretic Factor
1
2005
8
0.060
Why?
Atrial Natriuretic Factor
1
2005
25
0.060
Why?
Ear, Inner
1
2005
18
0.060
Why?
Melanoma
1
2008
278
0.060
Why?
Guanine
1
2004
40
0.060
Why?
Cell Physiological Phenomena
1
2004
3
0.060
Why?
Cell Cycle Proteins
1
2005
163
0.060
Why?
Cytochromes c
1
2003
28
0.050
Why?
DNA Adducts
1
2004
79
0.050
Why?
Salivary Proteins and Peptides
1
2003
8
0.050
Why?
Statistics as Topic
1
2003
86
0.050
Why?
Isoenzymes
1
2003
165
0.050
Why?
Base Pair Mismatch
1
2003
21
0.050
Why?
Adenocarcinoma, Follicular
1
2003
3
0.050
Why?
Adenocarcinoma, Papillary
1
2003
5
0.050
Why?
Tunica Intima
1
2003
55
0.050
Why?
Adenoma, Oxyphilic
1
2003
11
0.050
Why?
Cell Count
1
2003
150
0.050
Why?
Retrospective Studies
4
2007
6274
0.050
Why?
DNA-Binding Proteins
1
2005
410
0.050
Why?
Keratoacanthoma
1
2002
7
0.050
Why?
Collagen
1
2003
199
0.050
Why?
Renal Dialysis
1
2003
171
0.050
Why?
Platelet Aggregation Inhibitors
1
2003
174
0.050
Why?
Alcohol Drinking
1
2003
228
0.050
Why?
Combined Modality Therapy
4
2004
640
0.050
Why?
Molecular Sequence Data
1
2003
760
0.050
Why?
Lung
1
2005
493
0.050
Why?
Blotting, Western
2
2013
575
0.040
Why?
Adolescent
2
2012
6453
0.040
Why?
Cohort Studies
1
2005
1451
0.040
Why?
Prevalence
1
2004
967
0.040
Why?
Blood Platelets
1
2003
253
0.040
Why?
Tomography, X-Ray Computed
1
2006
1163
0.040
Why?
Smoking
1
2003
506
0.040
Why?
Random Allocation
2
2010
284
0.040
Why?
Quality of Life
1
2004
850
0.040
Why?
Electrophoresis, Agar Gel
2
2008
11
0.030
Why?
Sensitivity and Specificity
2
2010
855
0.030
Why?
Hyperplasia
2
2008
97
0.030
Why?
Neck Dissection
2
2008
30
0.030
Why?
Dose-Response Relationship, Drug
2
2011
1369
0.030
Why?
Fluorouracil
2
2004
59
0.030
Why?
Photosensitivity Disorders
2
2003
9
0.030
Why?
Cross-Sectional Studies
2
2012
1601
0.030
Why?
Infant
2
2012
3648
0.030
Why?
Lymph Node Excision
2
2004
131
0.030
Why?
Actins
1
2013
112
0.020
Why?
Head
1
2013
72
0.020
Why?
Neck
1
2013
100
0.020
Why?
Treatment Outcome
3
2011
5265
0.020
Why?
Lymphocele
1
2011
7
0.020
Why?
Tissue Survival
1
2011
10
0.020
Why?
Antigens, Nuclear
1
2011
23
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
44
0.020
Why?
Tissue Culture Techniques
1
2011
37
0.020
Why?
Transplantation, Heterologous
1
2011
73
0.020
Why?
Administration, Topical
1
2011
67
0.020
Why?
Time Factors
2
2010
2933
0.020
Why?
Mice, Nude
1
2011
247
0.020
Why?
Neoplasms, Squamous Cell
1
2010
7
0.020
Why?
Rats
2
2009
3262
0.020
Why?
Pharmacogenetics
1
2010
50
0.020
Why?
Granulation Tissue
1
2010
9
0.020
Why?
Tissue and Organ Harvesting
1
2010
24
0.020
Why?
Myeloid Cells
1
2010
37
0.020
Why?
Probability
1
2010
163
0.020
Why?
Endothelial Cells
1
2011
256
0.020
Why?
Carcinoma
1
2010
137
0.020
Why?
Pilot Projects
1
2011
694
0.020
Why?
Graft Rejection
1
2010
173
0.020
Why?
Neovascularization, Physiologic
1
2009
68
0.020
Why?
Thymine
1
2008
10
0.020
Why?
Chi-Square Distribution
1
2009
275
0.020
Why?
Centromere
1
2008
13
0.020
Why?
Microdissection
1
2008
18
0.020
Why?
Cell Line, Transformed
1
2008
73
0.020
Why?
Telomere
1
2008
35
0.020
Why?
Melanocytes
1
2008
38
0.020
Why?
Gene Dosage
1
2008
73
0.020
Why?
Fluorescent Dyes
1
2008
106
0.020
Why?
Iodine
1
2007
9
0.020
Why?
Genetic Markers
1
2008
104
0.020
Why?
Mice, Knockout
1
2010
840
0.020
Why?
Predictive Value of Tests
1
2010
924
0.020
Why?
Fatal Outcome
1
2008
197
0.020
Why?
Cluster Analysis
1
2007
209
0.020
Why?
Epithelial Cells
1
2008
203
0.020
Why?
Prospective Studies
1
2011
2378
0.020
Why?
Buffers
1
2005
9
0.020
Why?
Round Window, Ear
1
2005
6
0.020
Why?
Rats, Inbred Lew
1
2005
49
0.010
Why?
Injections
1
2005
58
0.010
Why?
Rats, Sprague-Dawley
1
2009
1556
0.010
Why?
Phosphates
1
2005
46
0.010
Why?
Sodium Chloride
1
2005
56
0.010
Why?
Mice, Inbred C57BL
1
2010
1796
0.010
Why?
Protein Isoforms
1
2005
116
0.010
Why?
Drug Combinations
1
2005
128
0.010
Why?
Antibodies
1
2005
151
0.010
Why?
Statistics, Nonparametric
1
2004
189
0.010
Why?
Reproducibility of Results
1
2007
1181
0.010
Why?
Disease-Free Survival
1
2005
439
0.010
Why?
Platelet Adhesiveness
1
2003
12
0.010
Why?
Elastin
1
2003
22
0.010
Why?
Up-Regulation
1
2005
446
0.010
Why?
Polytetrafluoroethylene
1
2003
32
0.010
Why?
DNA Primers
1
2003
205
0.010
Why?
Radiotherapy
1
2004
125
0.010
Why?
Anastomosis, Surgical
1
2003
65
0.010
Why?
Dogs
1
2003
185
0.010
Why?
Vascular Patency
1
2003
83
0.010
Why?
Radiotherapy, Adjuvant
1
2003
63
0.010
Why?
Myocytes, Smooth Muscle
1
2003
87
0.010
Why?
Chemotherapy, Adjuvant
1
2003
119
0.010
Why?
Extracellular Matrix
1
2003
109
0.010
Why?
Graft Occlusion, Vascular
1
2003
74
0.010
Why?
Thyroidectomy
1
2003
60
0.010
Why?
Biopsy, Needle
1
2003
179
0.010
Why?
Young Adult
1
2012
4075
0.010
Why?
Lymphatic Metastasis
1
2003
221
0.010
Why?
Stromal Cells
1
2002
75
0.010
Why?
Models, Biological
1
2003
717
0.010
Why?
Risk Assessment
1
2003
1268
0.010
Why?
Arkansas
1
2004
1974
0.010
Why?
Diagnosis, Differential
1
2002
1029
0.010
Why?
Pregnancy
1
2003
2444
0.010
Why?
Fan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description